Abstract
Several classification systems for the vasculitides have been developed over the second half of the past century. These classifications systems have been modified according to the advances made in the differentiation of these syndromes, particularly their histopathologic features (the vessel size involved) and their clinical features. Although these classifications have been widely used in the clinical setting for the diagnosis of these disorders, they were developed for research purposes. Given the common clinical and, sometimes, histopathologic features of the different vasculitides, a classification system that facilitates a diagnosis and the formulation of a therapeutic plan is still needed. The development and utilization of novel serum markers and new imaging modalities coupled with advances in the understanding of these disorders, may allow the development of a classification system for the vasculitides that will be of greater value in the clinical setting.
Similar content being viewed by others
References and Recommended Reading
Matteson EL: Notes on the history of eponymic idiopathic vasculitis: the diseases of Henoch and Schonlein, Wegener, Churg and Strauss, Horton, Takayasu, Behcet, and Kawasaki. Arthritis Care Res 2004, 13:237–245.
Lie JT: Nomenclature and classification of vasculitis: plus ça change, plus c’est la même chose. Arthritis Rheum 2004, 37:181–186. This is an editorial addressing the lack of important advances made in the most recent classification systems for the vasculitides.
Matteson EL: Historical perspective of vasculitis: polyarteritis nodosa and microscopic polyangiitis. Curr Rheumatol Rep 2002, 4:67–74.
Jennette JC, Falk RJ: Clinical and pathological classification of ANCA-associated vasculitis: what are the controversies? Clin Exp Immunol 1995, 101:18–22.
Alarcón-Segovia D: The necrotizing vasculitides. A new pathogenetic classification. Curr Rheumatol Rep 1977, 5:93–99.
Matteson EL: Historical perspective on the classification of vasculitis. Arthritis Care Res 2000, 13:122–127.
Luqmani R, Robinson H: Introduction to, and classification of, the systemic vasculitides. Best Pract Res Clin Rheumatol 2001, 15:187–202.
Scott DG, Watts RA: Classification and epidemiology of systemic vasculitis. Br J Rheumatol 1994, 33:897–900. In this editorial a new classification for the vasculitides is proposed that overcomes some of the limitations other classification systems have.
Jenette JC, Falk RJ: Do vasculitis categorization systems really matter? Curr Rheumatol Rep 2000, 2:430–438. In this review the authors address the prognostic and treatment differences between the different vasculitides to warrant the development of diagnostic categories.
Guillevin L, Lhote F: Classification and management of necrotizing vasculities. Drugs 1997, 53:805–816.
Watts RA, Scott DGI: Classification and epidemiology of the vasculitides. Baillieres Clin Rheumatol 1997, 11:191–217.
Gonzalez-Gay MA, Garcia-Porrua C: Epidemiology of the vasculitides. Rheum Dis Clin North Am 2001, 27:729–749.
Jennette JC, Falk RJ: Small-vessel vasculitis. N Engl J Med 1997, 337:1512–1523.
Lie JT: Histopathologic specificity of systemic vasculitis. Rheum Dis Clin North Am 1995, 21:883–909.
Zeek PM: Periarteritis nodosa: a critical review. Am J Clin Pathol 1952, 22:777–790.
Heller I, Isakov A, Blinder-Weiner S, Topilsky M: Bayesian classification of vasculitis: a simulation study. Methods Inf Med 1995, 34:259–265.
Rao JK, Allen NB, Pincus T: Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis. Ann Intern Med 1998, 129:345–352.
Sorensen SF, Slot O, Tvede N, Petersen J: A prospective study of vasculitis patients collected in a five year period: evaluation of the Chapel Hill nomenclature. Ann Rheum Dis 2004, 59:478–482.
Davies DJ, Moran JE, Niall JF, Ryan GB: Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? Br Med J 1982, 285:606.
van der Woude FJ, Rasmussen N, Lobatto S, et al.: Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener’s granulomatosis. Lancet 1985, 1:425–429.
Savige J, Gillis D, Benson E, et al.: International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies. Am J Clin Pathol 1999, 111:507–513.
Hagen EC, Daha MR, Hermans J, et al.: Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int 1998, 53:743–753.
Wiik A: Anti-neutrophil cytoplasmic antibodies tests: which tests should be used in practice? Intern Med 2001, 40:466–470.
Schonermarck U, Lamprecht P, Csernok E, Gross WL: Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA. Rheumatology 2001, 40:178–184.
Hunder GG, Arend WP, Bloch DA, et al.: The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum 1990, 33:1065–1067.
Fries JF, Hunder GG, Bloch DA, et al.: The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum 1990, 33:1135–1136.
Jennette JC, Falk RJ, Andrassy K, et al.: Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994, 37:187–192.
Cotch MF: The socioeconomic impact of vasculitis. Curr Opin Rheumatol 2000, 12:20–23.
Jayne D: Update on the European vasculitis study group trials. Curr Opin Rheumatol 2001, 13:48–55.
Gross WL, Trabandt A, Reinhold-Keller E: Vasculitis: aims of therapy/Guest Editor: R. Watts. Diagnosis and evaluation of vasculitis. Rheumatology 2000, 39:245–252.
Bruce IN, Bell AL: A comparison of two nomenclature systems for primary systemic vasculitis. BJR 1997, 36:453–458.
Watts RA, Jolliffe VA, Carruthers DM, et al.: Effect of classification on the incidence of polyarteritis nodosa and microscopic polyangiitis. Arthritis Rheum 1996, 39:1208–1212.
Jennette JC, Falk RJ: Diagnostic classification of antineutrophil cytoplasmic autoantibody-associated vasculitides. Am J Kidney Dis 1991, 18:184–187.
Stone JH, Talor M, Stebbing J, et al.: Test characteristics of immunofluorescence and ELISA tests in 856 consecutive patients with possible ANCA-associated conditions. Arthritis Care Res 2000, 13:424–434.
Hoffman GS: Classification of the systemic vasculitides: antineutrophil cytoplasmic antibodies, consensus and controversy. Clin Exp Rheumatol 1998, 16:111–115. This is a comprehensive editorial about the limitations vasculitides classifications share, as well as the role ANCA have in the diagnosis and in the pathogenesis of these disorders.
Falk RJ, Jennette JC: ANCA are pathogenic—oh yes they are!. J Am Soc Nephrol 2002, 13:1740–1749.
Seo P, Stone JH: The antineutrophil cytoplasmic antibodyassociated vasculitides. Am J Med 2004, 17:39–50.
Lane SE, Watts RA, Barker THW, Scott DGI: Evaluation of the Sorensen diagnostic criteria in the classification of systemic vasculitis. Rheumatology 2002, 41:1138–1141.
Neer CS, Watson KC, Stanton FJ: Recent experience in total shoulder replacement. J Bone Joint Surg 1982, 64-A:319–337.
Hunder GG: The use and misuse of classification and diagnostic criteria for complex diseases. Ann Intern Med 1998, 129:417–418.
Angeli E, Vanzulli A, Venturini M, et al.: The role of radiology in the diagnosis and management of Takayasu’s arteritis. J Nephrol 2001, 14:514–524.
Buckley A, Southwood T, Culham G, et al.: The role of ultrasound in evaluation of Takayasu’s arteritis. J Rheumatol 1991, 18:1073–1080.
Matsunaga N, Hayashi K, Sakamoto I, et al.: Takayasu arteritis: MR manifestations and diagnosis of acute and chronic phase. J Magn Reson Imaging 1998, 8:406–414.
Luqmani RA, Bacon PA, Moots RJ, et al.: Birmingham vasculitis activity score (BVAS) in systemic necrotizing vasculitis. Q J Med 1994, 87:671–678.
Whiting-O’Keefe QE, Stone JH, Hellmann DB: Validity of a vasculitis activity index for systemic necrotizing vasculitis. Arthritis Rheum 1999, 42:2365–2371.
Exley AR, Bacon PA, Luqmani RA, et al.: Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum 1997, 40:371–380.
Ware JE, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 31:247–263.
Abu-Shakra M, Smythe H, Lewtas J, et al.: Outcome of polyarteritis nodosa and Churg-Strauss syndrome. An analysis of twenty-five patients. Arthritis Rheum 1994, 37:1798–1803.
Furukawa S, Matsubara T, Yone K, et al.: Kawasaki disease differs from anaphylactoid purpura and measles with regard to tumour necrosis factor-alpha and interleukin 6 in serum. Eur J Pediatr 1992, 151:44–47.
Adam B, Calikoglu E: Serum interleukin-6, procalcitonin and C-reactive protein levels in subjects with active Behcet’s disease. J Eur Acad Dermatol Venereol 2004, 18:318–320.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bertoli, A.M., Alarcón, G.S. Classification of the vasculitides: Are they clinically useful?. Curr Rheumatol Rep 7, 265–269 (2005). https://doi.org/10.1007/s11926-005-0035-6
Issue Date:
DOI: https://doi.org/10.1007/s11926-005-0035-6